Collectively, our data suggest that pemafibrate can promote revascularization in response to ischemia, at least in part, by its ability to promote endothelial cell function through direct and FGF21-mediated activation of eNOS in endothelial cells (S8 Fig). The gene discussed is FGF21; the disease is ischemia.